rs116795025

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_017950.4(CCDC40):​c.1132G>A​(p.Ala378Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000578 in 1,582,168 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0032 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00030 ( 0 hom. )

Consequence

CCDC40
NM_017950.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.178

Publications

4 publications found
Variant links:
Genes affected
CCDC40 (HGNC:26090): (coiled-coil domain 40 molecular ruler complex subunit) This gene encodes a protein that is necessary for motile cilia function. It functions in correct left-right axis formation by regulating the assembly of the inner dynein arm and the dynein regulatory complexes, which control ciliary beat. Mutations in this gene cause ciliary dyskinesia type 15, a disorder due to defects in cilia motility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
CCDC40 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 15
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autoimmune disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043277442).
BP6
Variant 17-80050256-G-A is Benign according to our data. Variant chr17-80050256-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260948.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00322 (490/152282) while in subpopulation AFR AF = 0.0114 (474/41562). AF 95% confidence interval is 0.0106. There are 1 homozygotes in GnomAd4. There are 232 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC40NM_017950.4 linkc.1132G>A p.Ala378Thr missense_variant Exon 7 of 20 ENST00000397545.9 NP_060420.2
CCDC40NM_001243342.2 linkc.1132G>A p.Ala378Thr missense_variant Exon 7 of 18 NP_001230271.1
CCDC40NM_001330508.2 linkc.1132G>A p.Ala378Thr missense_variant Exon 7 of 11 NP_001317437.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC40ENST00000397545.9 linkc.1132G>A p.Ala378Thr missense_variant Exon 7 of 20 5 NM_017950.4 ENSP00000380679.4

Frequencies

GnomAD3 genomes
AF:
0.00321
AC:
488
AN:
152164
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0114
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000675
AC:
129
AN:
191060
AF XY:
0.000575
show subpopulations
Gnomad AFR exome
AF:
0.0113
Gnomad AMR exome
AF:
0.000321
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000399
GnomAD4 exome
AF:
0.000297
AC:
425
AN:
1429886
Hom.:
0
Cov.:
34
AF XY:
0.000241
AC XY:
171
AN XY:
709098
show subpopulations
African (AFR)
AF:
0.0115
AC:
374
AN:
32566
American (AMR)
AF:
0.000379
AC:
15
AN:
39602
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25592
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37776
South Asian (SAS)
AF:
0.0000362
AC:
3
AN:
82828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50290
Middle Eastern (MID)
AF:
0.000242
AC:
1
AN:
4132
European-Non Finnish (NFE)
AF:
0.00000273
AC:
3
AN:
1097988
Other (OTH)
AF:
0.000491
AC:
29
AN:
59112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
26
53
79
106
132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00322
AC:
490
AN:
152282
Hom.:
1
Cov.:
32
AF XY:
0.00312
AC XY:
232
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0114
AC:
474
AN:
41562
American (AMR)
AF:
0.000849
AC:
13
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68020
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
26
53
79
106
132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00155
Hom.:
1
Bravo
AF:
0.00363
ESP6500AA
AF:
0.0124
AC:
51
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000776
AC:
92
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 16, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 06, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
3.6
DANN
Benign
0.91
DEOGEN2
Benign
0.062
.;T;.;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.091
N
LIST_S2
Benign
0.60
T;T;T;T
MetaRNN
Benign
0.0043
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.3
L;L;L;L
PhyloP100
0.18
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.70
N;N;N;N
REVEL
Benign
0.033
Sift
Benign
0.52
T;T;T;T
Sift4G
Benign
0.36
T;T;T;T
Polyphen
0.045, 0.79
.;B;.;P
Vest4
0.23
MVP
0.067
MPC
0.17
ClinPred
0.0026
T
GERP RS
-1.7
Varity_R
0.025
gMVP
0.031
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116795025; hg19: chr17-78024055; API